Tumor spectrum analysis in p53-mutant mice

Hollstein, 1991, p53 mutations in human cancers, Science, 253, 49, 10.1126/science.1905840

Malkin, 1990, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms, Science, 250, 1233, 10.1126/science.1978757

Malkin, 1993, p53 and the Li-Fraumeni syndrome, Cancer Genet Cytogenet, 66, 83, 10.1016/0165-4608(93)90233-C

Kastan, 1991, Participation of p53 protein in the cellular response to DNA damage, Cancer Res, 51, 6304

Kastan, 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia telangiectasia, Cell, 71, 587, 10.1016/0092-8674(92)90593-2

Yin, 1992, Wild-type p53 restores cell-cycle control and inhibits gene amplification in cells with mutant p53 alleles, Cell, 70, 937, 10.1016/0092-8674(92)90244-7

Livingstone, 1992, Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53, Cell, 70, 923, 10.1016/0092-8674(92)90243-6

Clarke, 1993, Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature, 362, 849, 10.1038/362849a0

Lowe, 1993, p53 is required for radiation-induced apoptosis in mouse thymocytes, Nature, 362, 847, 10.1038/362847a0

Kern, 1991, Identification of p53 as a sequence-specific DNA binding protein, Science, 252, 1708, 10.1126/science.2047879

Wu, 1993, The p53-mdm-2 autoregulatory feedback loop, Genes Dev, 7, 1126, 10.1101/gad.7.7a.1126

Farmer, 1992, Wild-type p53 activates transcription in vitro, Nature, 358, 83, 10.1038/358083a0

Kern, 1992, Oncogenic forms of p53 inhibit p53-regulated gene expression, Science, 256, 827, 10.1126/science.1589764

Seto, 1992, Wild-type p53 binds to the TATA-binding protein and represses transcription, Proc Natl Acad Sci USA, 89, 12028, 10.1073/pnas.89.24.12028

Zambetti, 1992, Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element, Genes Dev, 6, 1143, 10.1101/gad.6.7.1143

Mack, 1993, Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53, Nature, 363, 281, 10.1038/363281a0

Donehower, 1992, Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours, Nature, 356, 215, 10.1038/356215a0

Mansour, 1988, Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes, Nature, 336, 348, 10.1038/336348a0

Wade-Evans, 1985, Precise epitope mapping of the murine transformation-associated protein, p53, EMBO J, 4, 699, 10.1002/j.1460-2075.1985.tb03686.x

Hinds, 1989, Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation, J Virol, 63, 739, 10.1128/JVI.63.2.739-746.1989

Dittmer, 1993, Gain of function mutations in p53, Nature Genet, 4, 42, 10.1038/ng0593-42

Wolf, 1984, Reconstitution of p53 expression in a non-producer Ab-MuLV-transformed cell line by transfection of a functional p53 gene, Cell, 38, 119, 10.1016/0092-8674(84)90532-4

Von Boehmer, 1988, The developmental biology of T lymphocytes, Ann Rev Immunol, 6, 309, 10.1146/annurev.immunol.6.1.309

Capecchi, 1989, Altering the genome by homologous recombination, Science, 244, 1288, 10.1126/science.2660260

Lane, 1993, A death in the life of p53, Nature, 362, 786, 10.1038/362786a0

Debbas, 1993, Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B, Genes Dev, 7, 546, 10.1101/gad.7.4.546

Lowe, 1993, p53-dependent apoptosis modulates the cytoxicity of anticancer agents, Cell, 74, 957, 10.1016/0092-8674(93)90719-7

Jacks, 1992, Effects of an Rb mutation in the mouse, Nature, 359, 295, 10.1038/359295a0

Clarke, 1992, Requirement for a functional Rb-1 gene in murine development, Nature, 359, 328, 10.1038/359328a0

Lee, 1992, Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis, Nature, 359, 288, 10.1038/359288a0

Hanahan, 1989, Transgenic mice as probes into complex systems, Science, 246, 1265, 10.1126/science.2686032

Bienz, 1984, Analysis of the gene coding for the murine cellular tumour antigen p53, EMBO J, 3, 2179, 10.1002/j.1460-2075.1984.tb02110.x

Tybulewicz, 1991, Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene, Cell, 65, 1153, 10.1016/0092-8674(91)90011-M

Gossler, 1986, Transgenesis by means of blastocyst-derived embryonic stem cell lines, Proc Natl Acad Sci USA, 83, 9065, 10.1073/pnas.83.23.9065

Bradley, 1987, Production and analysis of chimaeric mice, 113

Robertson, 1987, Embryo-derived stem cell lines, 72